Page 38 - RxBound-Winter2016-extended
P. 38
Fadi Khasawneh was presented witth the
Harriet K. & Philip Pumerantz Award for Leadership
at Convocation, August 2015
Lyna Luo, PhD, received a two-year $397,360 (total cost) Mark Nguyen, PharmD, has been promoted to Associate
multi-PI grant with Dr. Michel Baudry (GCBS) on their Professor of Pharmacy Practice and Administration.
NIH/NINDS R21 grant titled “Development of a selective
calpain-2 inhibitor for the treatment of Angelman Emmanuelle Schwartzman, PharmD, Faculty advisor for
Syndrome.” Gamma Sigma Chapter of Rho Chi Society and Chapter
President, Shawn Healer, is being recognized for its project
Kabir Lutfy, PhD, received a 3-year grant in the amount of proposal, “Match Me” Rho Chi Residency Education Series.
$475,000 entitled “The role of endogenous PACAP in The award includes $500 and an engraved plaque which will
nicotine addiction,” from the University of California, be presented at the Society’s Annual Meeting in March, 2016.
Tobacco-Related Disease Research Program (TRDRP).
Dr. Lutfy and Dr. Zaveri of Astraea Therapeutics, LLC were James Scott, PharmD, has been promoted to Professor of
funded an NIH/NIAAA SBIR Phase II grant entitled Pharmacy Practice and Administration. He was also named
“Development of Nociceptin Receptor Agonists for Alcohol as a Fellow by both the American Society of Health-system
Use Disorders.” Dr. Lutfy received a subcontract in the Pharmacy and the California Society of Health-system
amount of $276,714 on this collaborated research project. Pharmacy. He has also been appointed to the CSHP Board
of Directors
Dr. Lutfy is also a co-investigator and will be working with
Virginia Commonwealth University’s principal investigator, Jeffrey Wang, PhD, received a $30,000 gift from Saratoga,
Dr. Carmen Sato-Bigbee, on the project entitled “The Role of California-based Eureka BioVenture Partners, LLC to support
Mu-Opioid/Nociceptin-Orphanin FQ Receptor System in Dr. Wang’s research in the development of silkworms as
Oligodendrocyte Development and Remyelination.” The Sub- innovative in vivo models for drug discovery studies. Dr. Wang
Award is approximately $20,000 per year for three years. also co-organized a concurrent session Proteins and Peptides in
David Min, PharmD, has been awarded a restricted grant Drug Delivery and gave a presentation entitled “Lipid
from the Mendez National Institute of Transplantation Conjugates in Peptide Drug Delivery” at the 15th International
Foundation in the amount of $49,575 to support his research Symposium of the Society of Chinese Bio-scientists in America,
on “Glycosylation pattern as a novel diagnostic marker for June 25-29, 2016 in Taipei, Taiwan, ROC.
antibody medicated rejection in kidney transplant patients.” Dr. Wang was invited to speak at the United States
Pharmacopeia’s 2nd Peptide Workshop on November 2-3,
Arbi Nazarian, PhD, received $446,000 in funding for his 2016 in in Rockville, Maryland. He presented on the rationale
National Institutes of Health (NIH) R15 grant entitled and approaches of using lipid conjugates for the
“Insulin Mechanism of Diabetes-Evoked Enhancement of pharmaceutical development of peptide therapeutics.
Nicotine Reward.” Dr. Wang recently joined the editorial advisory board of
Current Peptide and Protein Science.
36 WesternU, College of Pharmacy
Harriet K. & Philip Pumerantz Award for Leadership
at Convocation, August 2015
Lyna Luo, PhD, received a two-year $397,360 (total cost) Mark Nguyen, PharmD, has been promoted to Associate
multi-PI grant with Dr. Michel Baudry (GCBS) on their Professor of Pharmacy Practice and Administration.
NIH/NINDS R21 grant titled “Development of a selective
calpain-2 inhibitor for the treatment of Angelman Emmanuelle Schwartzman, PharmD, Faculty advisor for
Syndrome.” Gamma Sigma Chapter of Rho Chi Society and Chapter
President, Shawn Healer, is being recognized for its project
Kabir Lutfy, PhD, received a 3-year grant in the amount of proposal, “Match Me” Rho Chi Residency Education Series.
$475,000 entitled “The role of endogenous PACAP in The award includes $500 and an engraved plaque which will
nicotine addiction,” from the University of California, be presented at the Society’s Annual Meeting in March, 2016.
Tobacco-Related Disease Research Program (TRDRP).
Dr. Lutfy and Dr. Zaveri of Astraea Therapeutics, LLC were James Scott, PharmD, has been promoted to Professor of
funded an NIH/NIAAA SBIR Phase II grant entitled Pharmacy Practice and Administration. He was also named
“Development of Nociceptin Receptor Agonists for Alcohol as a Fellow by both the American Society of Health-system
Use Disorders.” Dr. Lutfy received a subcontract in the Pharmacy and the California Society of Health-system
amount of $276,714 on this collaborated research project. Pharmacy. He has also been appointed to the CSHP Board
of Directors
Dr. Lutfy is also a co-investigator and will be working with
Virginia Commonwealth University’s principal investigator, Jeffrey Wang, PhD, received a $30,000 gift from Saratoga,
Dr. Carmen Sato-Bigbee, on the project entitled “The Role of California-based Eureka BioVenture Partners, LLC to support
Mu-Opioid/Nociceptin-Orphanin FQ Receptor System in Dr. Wang’s research in the development of silkworms as
Oligodendrocyte Development and Remyelination.” The Sub- innovative in vivo models for drug discovery studies. Dr. Wang
Award is approximately $20,000 per year for three years. also co-organized a concurrent session Proteins and Peptides in
David Min, PharmD, has been awarded a restricted grant Drug Delivery and gave a presentation entitled “Lipid
from the Mendez National Institute of Transplantation Conjugates in Peptide Drug Delivery” at the 15th International
Foundation in the amount of $49,575 to support his research Symposium of the Society of Chinese Bio-scientists in America,
on “Glycosylation pattern as a novel diagnostic marker for June 25-29, 2016 in Taipei, Taiwan, ROC.
antibody medicated rejection in kidney transplant patients.” Dr. Wang was invited to speak at the United States
Pharmacopeia’s 2nd Peptide Workshop on November 2-3,
Arbi Nazarian, PhD, received $446,000 in funding for his 2016 in in Rockville, Maryland. He presented on the rationale
National Institutes of Health (NIH) R15 grant entitled and approaches of using lipid conjugates for the
“Insulin Mechanism of Diabetes-Evoked Enhancement of pharmaceutical development of peptide therapeutics.
Nicotine Reward.” Dr. Wang recently joined the editorial advisory board of
Current Peptide and Protein Science.
36 WesternU, College of Pharmacy
